Hospital.Help

Chicago – The combination with an mRNA vaccine, which is designed to alert the immune system to antigens in the tumor, can increase the chance of recurrence-free survival after resection of an advanced melanoma compared to treatment with a checkpoint inhibitor alone. The latest results of an ongoing phase 2 study were presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago…